Skip to main content
. 2008 Apr 5;79(3):492–499. doi: 10.1093/cvr/cvn088

Table 1.

Biochemical profiles of the study groups

Diet (high phosphate)
Control Low phosphate
Week 4 (n = 15) Week 9 (n = 15) Week 19 (n = 8) Week 9 (n = 10) Week 4 (n = 10)
Creatinine (mmol/L) 213 ± 3.78* 90 ± 1.47 80 ± 2.7 70 ± 3.6 207 ± 2.58
Phosphate (mmol/L) 4.20 ± 0.06* 2.62 ± 0.03 1.6 ± 0.02 2.5 ± 0.03 2.2 ± 0.06**
PTH (pg/mL) 2800 ± 40 750 ± 123 414 ± 37 281 ± 53 210 ± 40**
Total cholesterol (mmol/L) 3.14 ± 0.01 2.83 ± 0.03 2.1 ± 0.04
Alkaline phosphatase (U/L) 189 ± 6.33 173 ± 2.33 189 ± 1.2
Potassium (mmol/L) 5.92 ± 0.02 4.93 ± 0.07 5.8 ± 0.09

Biochemical profile obtained from three groups. In the diet group: at 4 weeks (during the adenine diet), at 9 weeks (2 weeks after cessation of diet), and at 19 weeks (the reversibility subgroup). In the low-phosphate group at 4 weeks and the control group at 9 weeks. At 4 weeks there was significant increase in creatinine, phosphate, and parathyroid hormone (PTH) levels in the diet group blood compared with the control; creatinine was similar to the low-phosphate group, while the phosphate and PTH were significantly higher. After 9 weeks, creatinine and phosphate level in the diet group decreased, while the PTH levels were still significantly higher than the controls. After 19 weeks, creatinine, phosphate, and PTH levels were normalized.

*P < 0.05 for the comparison of diet group with the control group.

P < 0.01 for the comparison of diet group with the control group.

**P < 0.05 for the comparison of diet group with the low-phosphate group.

The reversibility subgroup.

HHS Vulnerability Disclosure